Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in adolescent Stargardt 1 (STGD1) subjects, proceed without ...